This page is educational and not medical advice. A value outside the range printed on your lab report is worth discussing with a clinician, who decides what it reflects.
It measures the concentration of the oxygen-carrying protein inside red blood cells, reported in grams per deciliter from the same tube drawn for a complete blood count. Red cells load oxygen in the lungs and release it in tissue, and hemoglobin is the molecule doing that work. Because the result is a concentration rather than a total, it moves with two separate things, the number of red cells in circulation and the volume of plasma those cells float in. That single fact explains much of what follows on this page.
The marker itself, what it does, how the sample is handled and how to read a value against your own report, is covered in depth on the Hemoglobin page. The rest of this guide stays on one question, why a result can come back above the range printed on your lab report, and what a clinician works through next.
Compare the value with the reference range printed beside it on your lab report, because each laboratory sets its own range from its own instruments and the population it serves. A number that reads high on one report may sit inside the range on another.
| Hemoglobin | Range |
|---|---|
| Your laboratory's reference range | As printed on your lab report |
| FitScript optimal range | 14 to 16 g/dL |
| FitScript optimal range, women | 12 to 15 g/dL |
FitScript's optimal ranges are optimization targets, not diagnostic cut-offs. Reference ranges vary by lab, age and sex, which is why the printed range on your own report is the one that matters for reading your result.
One reading sitting just past the upper limit is a snapshot of a single morning, taken in whatever state of hydration, altitude and activity you happened to be in. Confirming that the rise is persistent on a repeat measurement, rather than acting on one draw, is the starting point of the assessment described in reviews of erythrocytosis 1. Hemoglobin, hematocrit and red cell count are measured from the same sample and move together, so a clinician reads all three rather than any one in isolation. A value above the printed range is worth discussing with a clinician, who decides whether it needs repeating and what it reflects for you.
It reflects one of two situations, either a true increase in the total mass of red cells in the body, or an unchanged red cell mass sitting in a reduced volume of plasma 1. Clinicians call the first an absolute erythrocytosis and the second a relative or apparent erythrocytosis, and separating them is the first fork in the road 2.
Absolute causes then split again. In a primary cause, the bone marrow produces red cells with little regard for the usual control signal. In a secondary cause, the signal itself is turned up, and the marrow is responding exactly as designed. That signal is erythropoietin, a hormone released mainly by the kidney when it senses that less oxygen is arriving. The kidney behaves like a sensor at the end of a long supply line. Anything that lowers the oxygen reaching it, thin air, a lung that cannot transfer oxygen well, a night of interrupted breathing, carbon monoxide occupying binding sites, can lift erythropoietin output and, over weeks, lift the red cell count.
This framework is why a clinician asks where you live, whether you smoke, how you sleep and what medicines you take before ordering anything further 2. The history narrows the field faster than any single test. It is also why a result outside the printed range is a question rather than an answer, and why the clinician, not the number, decides what it reflects.
Yes, losing plasma volume concentrates the red cells already in circulation, so the reading climbs without the body making a single extra cell, a pattern described as relative or apparent erythrocytosis 2. Heavy sweating, a stomach illness with fluid loss, a long flight, a sauna session before a blood draw, or a fasting morning with nothing to drink can all shrink plasma volume for a while.
Some medicines also change fluid balance, which can shift the reading; ask your prescriber about anything you take before reading too much into a single value. The practical consequence is simple. Two draws a fortnight apart, taken in different states of hydration, can produce two different hemoglobin numbers from the same unchanged body.
That is also why clinicians look at the trend rather than the spike. If the value settles back inside the printed range on a repeat draw taken on an ordinary day, the picture is different from a value that stays up across several measurements. Neither outcome is something to interpret alone, and a persistent rise is worth discussing with a clinician promptly.
The question of whether day-to-day pressure and sympathetic drive can themselves nudge red cell numbers comes up constantly, and it is unpacked separately in can stress cause high red blood cell count.
Yes. Research suggests that smoking is associated with a rise in red cell production and is one of the recognised causes of secondary erythrocytosis 1. The mechanism runs through carbon monoxide. Inhaled carbon monoxide binds hemoglobin far more tightly than oxygen does, forming carboxyhemoglobin and taking those binding sites out of service. The blood still contains plenty of hemoglobin, but less of it is available to carry oxygen, so tissue oxygen delivery falls.
The kidney registers that shortfall and raises erythropoietin output. Over weeks, the marrow answers with more red cells, and the hemoglobin concentration rises.
Two practical points follow. First, a smoking history belongs in the conversation before any further testing, because it changes how the rest of the workup is sequenced. Second, a measurement of carboxyhemoglobin is one of the tests a clinician can order when inhaled carbon monoxide is on the list of possible drivers 1. Whether and how to act on a smoking history, including any support for stopping, is a conversation for a licensed clinician rather than something to work out from a lab value.
Because the air at altitude holds less oxygen pressure, so each breath saturates the blood a little less, and the body compensates by building a larger carrying capacity. High-altitude residence is listed among the established causes of secondary erythrocytosis in reviews of the condition 1.
The sequence is the same oxygen-sensing loop. Lower arterial oxygen reaches the kidney, erythropoietin output rises, the marrow responds, and over weeks to months the red cell mass settles at a higher level. This is physiology doing its job, not a malfunction, and it is why a hemoglobin value read without knowing where someone lives can be misleading.
Altitude matters in a few quieter ways too. Someone who has recently moved up may be mid-adaptation when the blood is drawn. Someone who spends part of the year high and part low can show different values in different seasons.
None of that makes a high value something to set aside. Altitude adaptation and another cause can sit in the same person at the same time, so the value still belongs in front of a clinician, who weighs the altitude history alongside everything else before deciding what the number reflects.
Yes. Conditions that lower blood oxygen, including chronic lung disease and sleep-disordered breathing, are among the hypoxia-driven causes of secondary erythrocytosis described in the clinical evaluation of patients with a raised red cell mass 2.
The lung version is intuitive. When gas exchange is impaired, less oxygen crosses into the blood, arterial saturation falls, and the erythropoietin response follows. The sleep version is less visible, because the drops in oxygen happen during the night while the person is unaware of them. Repeated night-time dips can be enough to lift red cell production even when daytime saturation reads close to normal, which is why a clinician asks about snoring, daytime sleepiness and witnessed breathing pauses when a raised hemoglobin has no obvious explanation.
The tests that follow depend on the history. Pulse oximetry gives a quick reading of saturation, an arterial blood gas measures oxygen and carbon dioxide directly, overnight oximetry or formal sleep tests look at what happens across a night, and lung function tests assess how well the lungs move and exchange air. A guideline from the British Society for Haematology covers how specific situations in secondary erythrocytosis are approached 8.
What matters for a reader holding a lab report is that a raised hemoglobin can be the first visible sign of a breathing problem nobody has looked for yet. That makes it worth raising with a clinician rather than filing away.
Yes. Androgen and testosterone therapy is listed among the causes of secondary erythrocytosis in reviews of how a raised red cell mass is investigated 1. Androgens stimulate the marrow's red cell line and increase the availability of iron for building hemoglobin, so the red cell count and the hemoglobin concentration can both drift upward over months of therapy.
This is one reason blood counts are monitored during hormone therapy rather than checked once at the start. A value that was mid-range before therapy and now sits above the printed range is information a prescriber uses, and it is worth raising at the next review rather than waiting for the following annual draw.
Two boundaries are worth stating plainly. A licensed provider evaluates whether hormone therapy is appropriate for a given person in the first place, and the same provider decides what to do if blood counts rise during it. Treatment decisions belong to a licensed provider. Nothing on this page should be read as a reason to start, stop or alter any therapy.
It is also worth telling whoever reviews your labs about any hormone therapy, including anything obtained outside a clinical setting. Without that detail, a raised hemoglobin can send an investigation down a longer path than it needs to take.
The kidney is where oxygen sensing and erythropoietin production happen, so kidney conditions sit close to the centre of this topic. Erythrocytosis is associated with chronic kidney disease and with the period following a kidney transplant, as set out in a review of the two together 3.
There are two directions here, which can be confusing. Reduced kidney function can lower erythropoietin output and drag hemoglobin down. Yet a raised hemoglobin can also appear in kidney disease and after transplantation, which is the situation that review addresses 3. Both pictures are real, and which one appears depends on the person and the stage.
A separate route runs through growth of tissue that makes erythropoietin on its own. Kidney cysts and certain kidney tumours, along with a few tumours elsewhere, can release erythropoietin outside the normal feedback loop, and these are part of the standard list a clinician works through when a raised red cell mass has no hypoxic explanation 1. That is why kidney imaging appears in some workups and not others.
For a reader, the takeaway is narrow and useful. Kidney function markers belong alongside a raised hemoglobin, and the combination of the two is for a clinician to interpret, not a pattern to decode from a portal screen.
Polycythemia vera is a bone marrow condition in which red cell production continues largely independently of the usual erythropoietin signal, and it sits in the primary column of the causes list 4. It is the reason a persistently raised hemoglobin is taken seriously rather than waved through, even when a plausible secondary explanation exists.
Studies suggest that a JAK2 mutation is present in nearly all people with polycythemia vera, which is why JAK2 testing has become central to how the condition is assessed 4. Other features a clinician weighs include an erythropoietin level that sits low rather than high, changes in the platelet and white cell counts, an enlarged spleen, and symptoms such as itching after a warm bath or shower 6. No single one of those findings settles anything on its own.
Once the picture is established, hematologists group people by features including age and any history of clotting, which shapes how closely they are followed 5. Considerations for those placed in the lower-risk group are set out separately 9.
What a reader should take from this is not a self-assessment. A raised hemoglobin by itself says nothing about which column a person falls into. The point is that a persistent rise deserves a proper look, and that the look is structured, well described and carried out by clinicians who do it regularly.
A negative JAK2 result moves the investigation toward other explanations rather than ending it, and there is a defined approach to erythrocytosis without a JAK2 mutation 7. This situation is familiar enough to have its own name and its own update.
The work then returns to the secondary causes already covered, low blood oxygen from lung or sleep-related conditions, smoking and carbon monoxide exposure, altitude, hormone therapy, and tissue producing erythropoietin outside normal control 1. Many people turn out to have a secondary driver that was simply not obvious on the first pass.
Where no acquired cause emerges, clinicians consider inherited explanations. These include hemoglobin variants that hold onto oxygen too tightly, so tissue receives less than the saturation reading suggests, and changes affecting the oxygen-sensing pathway or the erythropoietin receptor that leave the system set at a higher output 7. A family history of high counts across generations is the clue that sends an assessment in this direction.
When a thorough search finds nothing, the picture is described as idiopathic erythrocytosis, which means the raised red cell mass is real and the cause has not been identified 2. That is not a dead end. It is a label that carries its own follow-up, decided by the clinician managing the case.
With a repeat measurement first, then a structured search that moves from the simple explanations outward 1. The order is deliberate, because confirming that the rise persists avoids chasing a value that reflected one dehydrated morning.
The history does the heavy lifting. A clinician asks where you live and how long you have lived there, whether you smoke or are exposed to carbon monoxide, how you sleep and whether anyone has heard you stop breathing, what medicines and hormone therapies you take, whether you have known lung or kidney conditions, and whether close relatives have had high counts or clotting events 2. The examination adds findings such as an enlarged spleen.
From there, tests are chosen to answer specific questions rather than ordered as a block. A serum erythropoietin level helps place the picture in the primary or secondary column. Oxygen saturation, an arterial blood gas, overnight oximetry or sleep tests address the hypoxia question. A carboxyhemoglobin measurement addresses carbon monoxide. JAK2 testing addresses the marrow question. Imaging of the kidneys addresses erythropoietin-producing tissue. Iron markers including ferritin are read alongside.
Particular situations, including pregnancy and surgery in people with erythrocytosis, are covered in a British Society for Haematology guideline 8. Anyone who is pregnant should ask their OB or midwife about their own results. Throughout, the clinician decides which tests are warranted and what the combination reflects.
Hematocrit and red cell count come first, because all three are measured from the same sample and rise and fall together. Hematocrit expresses the share of blood volume occupied by red cells rather than a protein concentration, and the reasons it climbs overlap heavily with the reasons covered here, which are set out in what causes high hematocrit.
Serum erythropoietin sits next in importance, since it separates a marrow running on its own from a marrow responding to a signal 1. Ferritin and iron studies are read alongside.
One frequent source of confusion deserves clearing up. Hemoglobin A1c shares a name with this marker but measures something entirely different, the share of hemoglobin carrying attached glucose, read as a picture of blood sugar over time. The distinction is worked through in is hemoglobin the same as a1c. A high hemoglobin and a high A1c are separate findings with separate explanations.
FitScript Essential is a lab panel a reader looking into this topic can review alongside their existing results. Atlas, FitScript's AI health advisor, organises results over time so changes are visible rather than buried in separate PDFs. A licensed clinician reviews the results and decides what they mean and what the next step is.
Some symptoms need emergency care regardless of what any lab value says, and they should never wait for a repeat blood test.
Call 911 or go to the emergency department for any of these:
Separately, these are worth booking a visit with a clinician promptly, without waiting for a routine annual check:
Please discuss your own results and any treatment with a clinician or licensed provider, who is the person able to weigh them against your history.
They are not the same measurement, but they move together because both come from the same blood sample. Hemoglobin is the concentration of the oxygen-carrying protein in grams per deciliter, while hematocrit is the share of blood volume made up of red cells. A clinician reads both alongside the red cell count rather than relying on either one alone.
Fluid status changes how concentrated the blood is, so a sample drawn after heavy sweating or an illness with fluid loss can read higher than one drawn on an ordinary day. That alone does not settle what is behind a result. A repeat test under steadier conditions, arranged by a clinician, is how the question gets answered.
A single reading is one snapshot taken under one set of conditions. A value outside the range printed on your lab report is worth discussing with a clinician, who decides whether it needs repeating and what it reflects. Several everyday factors can move a single draw in either direction.
No. Hemoglobin is the oxygen-carrying protein measured in grams per deciliter, while HbA1c measures the share of hemoglobin that has glucose attached to it and is read as a picture of blood sugar over time. A raised hemoglobin and a raised A1c are separate findings with separate explanations.
Living at altitude means less oxygen is available in each breath, and the body can respond by building more red cells over time. Hard training with heavy sweating can also concentrate the blood on the day of a draw. Tell whoever reviews your labs where you live and how you train, because it changes how the value reads.
Yes. FitScript's optimal range is 14 to 16 g/dL, and for women it is 12 to 15 g/dL, and these are optimization targets rather than diagnostic cut-offs. Your laboratory prints its own reference range next to your result, and a clinician interprets the value with your age, sex and situation in mind.
A blood draw from a vein, taken in the same tube used for a complete blood count. No special preparation is needed for the measurement itself. A clinician may still ask about fluid intake, smoking, altitude and recent travel before reading the result, since those details change how the number is interpreted.
A licensed clinician does. They decide whether to repeat the test, which further tests to order, and what any finding reflects in the context of your history. Treatment decisions belong to a licensed provider.